INCR
Intercure Ltd.
stockNASDAQ
intercure (dba canndoc) (nasdaq: incr) (tsx: incr.u) (tase: incr) is the leading, profitable, and fastest growing cannabis company outside of north america. canndoc, a wholly owned subsidiary of intercure, is israel's largest licensed cannabis producer and one of the first to offer good manufacturing practices (gmp) certified and pharmaceutical-grade medical cannabis products. intercure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of north america. for more information, visit: http://www.intercure.co.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 5.27 | 2026-09-30 | -2.88% | -2.285 |
| 1M | 5.39 | 2026-09-08 | -5.01% | -0.397 |
| 3M | 4.82 | 2026-07-07 | +6.13% | 0.595 |
| 6M | 3.75 | 2026-04-07 | +36.53% | 1.000 |
| 1Y | 8.08 | 2025-10-07 | -36.59% | 0.940 |
| 2Y | 9.30 | 2024-10-07 | -44.95% | — |
| 5Y | 34.15 | 2021-10-07 | -85.01% | 0.746 |
Intercure Ltd. (NASDAQ:INCR) stock price today is $5.12, and today's volume is 7,712. INCR is down 3.759% today. The 30 day average volume is 11,616. INCR market cap is $76.82M with 15.00M shares outstanding.